Ionis Pharmaceuticals Inc (IONS) gets rating Upgrade from JP Morgan

Jaxson Clark

Ionis Pharmaceuticals Inc’s recently made public that its Officer Swayze Eric acquired Company’s shares for reported $1.62 million on Jan 02 ’26. In the deal valued at $69.02 per share,23,463 shares were bought.

Then, WENDER JOSEPH H sold 28,000 shares, generating $2,262,848 in total proceeds. Upon selling the shares at $80.82, the Director now owns 36,035 shares.

Before that, Joseph Wender bought 14,479 shares. Ionis Pharmaceuticals Inc shares valued at $1,187,133 were divested by the Director at a price of $81.99 per share.

JP Morgan upgraded its Ionis Pharmaceuticals Inc [IONS] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Goldman’s analysts, who increased its forecast for the stock in late September from “a Sell” to “a Neutral”. BMO Capital Markets also remained covering IONS and has increased its forecast on September 03, 2025 with a “an Outperform” recommendation from previously “Market perform” rating. Morgan Stanley revised its rating on July 31, 2025. It rated IONS as “an Overweight” which previously was an “an Equal-weight”.

Price Performance Review of IONS

On Friday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock jump 0.71% to $79.67. Over the last five days, the stock has lost -1.22%. Ionis Pharmaceuticals Inc shares have risen nearly 128.15% since the year began. Nevertheless, the stocks have risen 0.71% over the past one year. While a 52-week high of $83.61 was reached on 01/02/26, a 52-week low of $23.95 was recorded on 01/02/26.

Levels Of Support And Resistance For IONS Stock

The 24-hour chart illustrates a support level at 78.39, which if violated will result in even more drops to 77.11. On the upside, there is a resistance level at 80.58. A further resistance level may holdings at 81.49.

How much short interest is there in Ionis Pharmaceuticals Inc?

A steep rise in short interest was recorded in Ionis Pharmaceuticals Inc stocks on 2025-12-15, growing by 1.86 million shares to a total of 16.09 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 14.22 million shares. There was a rise of 11.58%, which implies that there is a positive sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.